Genomics Services Market Size, Share & Trends Analysis Report by Type of Service (Sequencing Services, Microarray Services, Bioinformatics Services, Others (e.g., PCR, NGS Library Preparation)), by Technology (Next-Generation Sequencing (NGS), Sanger Sequencing, Microarray, PCR, Others), Research Type, Mode of Delivery, Business Model, Application, End User and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2025–2035
|
Market Structure & Evolution
|
- The global genomics services market is valued at USD 6.7 billion in 2025.
- The market is projected to grow at a CAGR of 9.2% during the forecast period of 2025 to 2035.
|
|
Segmental Data Insights
|
- The sequencing services segment accounts for approximately 70% of the global genomics services market in 2025, driven by advanced, cost-effective technologies and growing use in medicine, research, and diagnostics.
|
|
Demand Trends
|
- Rising cancer, genetics, and chronic disease cases are boosting demand, with next‑generation sequencing used in over 60% of genomic analyses.
- Growing use of personalized medicine and genomic diagnostics is driving adoption across hospitals, research institutes, and biotech firms worldwide.
|
|
Competitive Landscape
|
- The global genomics services market is highly consolidated, with the top five players accounting for nearly 70% of the market share in 2025.
|
|
Strategic Development
|
- In August 2025, Agilent Technologies, Inc. launched a brand new suite of automated genomic sample preparation kits
- In September 2025, Eurofins Scientific expanded its genomics services portfolio by launching high-throughput whole-genome sequencing solutions
|
|
Future Outlook & Opportunities
|
- Genomics services market is likely to create the total forecasting opportunity of over USD 9.5 Bn till 2035
- North America is most attractive region
|
Genomics Services Market Size, Share, and Growth
The global genomics services market is experiencing robust growth, with its estimated value of USD 6.7 billion in the year 2025 and USD 16.2 billion by 2035, registering a CAGR of 9.2%. North America leads the market with market share of 47% with USD 3.1 billion revenue.

Matt Sause, Roche Diagnostics CEO, stated, "By enhancing our next-generation sequencing capabilities with SBX technology and collaborating with Broad Clinical Labs, we are demonstrating our intention to provide rapid, scalable, and high-quality genomic services to enable precise and life-saving insights in marketplaces around the world."
The global genomics services market is growing rapidly, driven by healthcare needing precision medicine, rising interest in research related to complex diseases, and applications related to agriculture/food systems and diagnostics.
Next-generation sequencing and data analysis based on artificial intelligence (AI) are contributing to greater accuracy at decreasing costs, allowing better and more wide-spread adoption in clinical and research settings. Due to tightening compliance requirements and organization requirements of the proper securing of data, companies are investing a lot of time, effort, and money in transparent processes and quality control.
However, key organizations within genomics such as Illumina, Thermo Fisher, and BGI Genomics, are continuing to respond to the complexities by vertical integration strategies, enhancements within sequencing capabilities, and precise bioinformatics solutions to add reliability and scalability to genomics services and the documentation and importantly safety requirements of health care.
Overall, this rapidly evolving landscape is reshaping genomics services, driving both innovation and transformation across the sector with strengthening supply chains that support personalized health care and the advancement of scientific inquiry across the globe.

Genomics Services Market Dynamics and Trends
Drivers: Growth Driven by Real-Time Monitoring and Rising Research in Genomics Services Market
- The genomics services market is rapidly changing and expanding due in no small part to advances in real-time monitoring solutions as well as increasing applications in clinical and research settings. Real-time genomic sequencing and analysis provides versatile, timely, and highly precise insights into genetic conditions and cancer mutations, as well as infectious diseases which allows physicians to provide timely diagnosis and personalized treatment plans.
- Additionally, the increasing volume of research studies and clinical trials focusing on genomics driven precision medicine has led to increased demand for sequencing and bioinformatics services worldwide.
- Moreover hospitals, biotechnology companies, and research institutions are investing heavily in next generation sequencing solutions and AI based interpretation tools in order to try to get faster/accurate results. We believe this expansion is fueled by the growing awareness of the value genomics is capable of providing in predictive healthcare as well as providing patients with tailored therapies.
Restraints: Genomics Services Market Growth Challenged by Cost and Data Privacy Concerns
- Due to advances in the emerging field of real-time monitoring technologies, along with the increase in genetic testing being done worldwide, the genomics services market is witnessing substantial growth. Real-time monitoring technologies, especially next generation sequencing technologies, and AI-propelled and AI-supported data analysis technologies have enabled quicker and more accurate insights to advance, support, and enable the personalization of medicine to improve patient outcomes.
- Conversely, the high costs associated with genomic sequencing and infrastructure remains an obstacle for market penetration and growth, particularly in developing countries. Meanwhile, there is hesitation for further penetration into the genomics services market due to concerns regarding data privacy, regulatory compliance and ethical uses of sensitive genetic information.
Opportunity: Opportunities Grow with Expanding Healthcare Infrastructure and Aging Population
- The genomics services market is expected to witness structured growth alongside the expansion of healthcare infrastructure globally and an older population. The growth of hospital and diagnostics center’s deployment of genomic technology will help improve access to personalized medicine and genetic testing.
- Likewise, the global aging population is also starting to drive more demand for genetic testing due to their vulnerability to chronic disease, as well as increased awareness with regards to early diagnosis and demand for more personalized and targeted treatment. In addition, enhanced awareness on preventive healthcare, as well as government interest and support for genomics research gives new opportunities for the genomics services ecosystem to expand further.
- Opportunities are available for companies to access new and innovating genomic solutions in parallel with meeting the demands of patients and healthcare stakeholders as they continue to evolve globally.
Key Trend: Genomics Services Market Driven by Precision Medicine and AI-Enabled Data Analytics
- The genomics services market is rapidly changing with extensive movement toward precision medicine and further data analysis through artificial intelligence. New sequencing technology, supported by artificial intelligence, helps produce better insight from genetic data which in turn can create customized treatment plans for patients.
- Further, advances in real-time data measurements and more extensive machine learning algorithms to measure factors, improve accuracy, lower turn-around times, and enhance predictive diagnostics. In addition, trends of increased utilization of liquid biopsy testing and non-invasive testing also broaden the potential uses of genomics. As healthcare providers continue to reflect a focus on tailored therapies, this market is heading towards strategies to succeed through technological advances while fulfilling the requests for equally effective and efficient genetic testing services.
Genomics Services Market Analysis and Segmental Data

Sequencing Services Maintain Dominance in Global Market amid Growing Demand for Personalized Medicine
- Sequencing services remain the leading category in the global genomics market because they are crucial for addressing the need for innovative healthcare provisions that personalize healthcare options. Technological advances in next-generation sequencing (NGS) instruments have resulted in genomic analysis that is faster, better and cheaper than previous models, causing the adoption of genomic information to be realized across research and clinical environments.
- Moreover, the emerging emphasis on personalized medicines inside cancer therapy strategies, rare disease treatment, and/or the added precision for inherited syndromes has expanded the demand for sequencing services supported by advanced molecular diagnostics. The continued challenge of expensive infrastructure models and complex data offers no respite, however the shift towards precision medicine indicates that sequencing services will remain indispensable in genomics applications around the world.
North America Dominates the Genomics Services Market, Driven by Advanced Research Infrastructure and Strong Healthcare Investment
- North America is positioned the best in the genomics services market because of stronger research institutions, acceptance of new technologies, and higher healthcare expenditure. Strong government funding and private interest in genomics research has strengthened innovation in sequencing, which further stimulated analytics demand.
- Because there is much higher occurrence of chronic and genetic illness amongst patients, that are driving demand for personalized medicine. There is also a strong regulatory setting and growing awareness that patients and healthcare providers have that have and will motivate adoption of genomics services. North America is solidified as a top player and global leader in genomics.
Genomics Services Market Ecosystem
The genomics services market has high consolidated ecosystem with Tier 1 players including Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, and QIAGEN N.V. These companies dominate the market through their advanced technology and their far-reaching global presence. They had Tier 2 companies like BGI Group, Eurofins Scientific, and Macrogen Inc., and Tier 3 companies create competitive diversity in the marketplace resulting in a competitive but balanced ecosystem. Buyer power is moderate because of the long term partnership potential for genomic services, while supplier power is moderate to high given the limited number of technology providers and key suppliers of reagents.

Recent Development and Strategic Overview:
- In August 2025, Agilent Technologies, Inc. launched a brand new suite of automated genomic sample preparation kits aimed at increasing accuracy and speed for next-generation sequencing workflows. The kits include integrated barcoding technology, which helps labs track samples more accurately, reducing errors along the way and increasing efficiency and reliability for genetic testing.
- In September 2025, Eurofins Scientific expanded its genomics services portfolio by launching high-throughput whole-genome sequencing solutions. The new service encompasses data analytics and secured digital tracking with fast turnaround times and improved data integrity for both clinical and research globally.
Report Scope
|
Attribute
|
Detail
|
|
Market Size in 2025
|
USD 6.7 Bn
|
|
Market Forecast Value in 2035
|
USD 16.2 Bn
|
|
Growth Rate (CAGR)
|
9.2%
|
|
Forecast Period
|
2025 – 2035
|
|
Historical Data Available for
|
2021 – 2024
|
|
Market Size Units
|
USD Bn for Value
|
|
Report Format
|
Electronic (PDF) + Excel
|
|
Regions and Countries Covered
|
|
North America
|
Europe
|
Asia Pacific
|
Middle East
|
Africa
|
South America
|
- United States
- Canada
- Mexico
|
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Nordic Countries
- Poland
- Russia & CIS
|
- China
- India
- Japan
- South Korea
- Australia and New Zealand
- Indonesia
- Malaysia
- Thailand
- Vietnam
|
- Turkey
- UAE
- Saudi Arabia
- Israel
|
- South Africa
- Egypt
- Nigeria
- Algeria
|
|
|
Companies Covered
|
- Agilent Technologies, Inc.
- BaseClear B.V.
- BGI Group
|
- CD Genomics
- CosmosID
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd
|
- Gene by Gene, Ltd.
- Genewiz (A Brooks Life Sciences Company)
- Illumina, Inc.
- Macrogen Inc.
|
|
- PerkinElmer, Inc.
- QIAGEN N.V.
- SciGenom Labs Pvt. Ltd.
- Stratos Genomics (a Roche company)
|
- Thermo Fisher Scientific Inc.
- Veritas Genetics
- Other key Players
|
Genomics Services Market Segmentation and Highlights
|
Segment
|
Sub-segment
|
|
By Type of Service
|
- Sequencing Services
- Microarray Services
- Bioinformatics Services
- Others (e.g., PCR, NGS Library Preparation)
|
|
By Technology
|
- Next-Generation Sequencing (NGS)
- Sanger Sequencing
- Microarray
- PCR
- Others
|
|
By Research Type
|
- Functional Genomics
- Epigenomics
- Metagenomics
- Transcriptomics
- Proteomics
- Others
|
|
By Mode of Delivery
|
- On-site Services
- Off-site Services
|
|
By Business Model
|
- Outsourced Services
- In-house Services
|
|
By Application
|
- Drug Discovery and Development
- Diagnostics
- Agriculture and Animal Research
- Personalized Medicine
- Others
|
|
By End User
|
- Hospitals and Clinics
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
- Diagnostic Laboratories
- Others
|
Frequently Asked Questions
The global genomics services market was valued at USD 6.7 Bn in 2025
The global genomics services market industry is expected to grow at a CAGR of 9.2% from 2025 to 2035
Key factors driving demand for genomics services include advancements in sequencing technologies, rising prevalence of genetic disorders, and growing adoption of personalized medicine.
In terms of genomics services market, the sequencing services segment accounted for the major share in 2025.
North America is a more attractive region for vendors.
Key players in the global genomics services market include prominent companies such as Agilent Technologies, Inc., BaseClear B.V., BGI Group, CD Genomics, CosmosID, Eurofins Scientific, F. Hoffmann-La Roche Ltd, Gene by Gene, Ltd., Genewiz (A Brooks Life Sciences Company), Illumina, Inc., Macrogen Inc., MedGenome Labs Ltd., Novogene Co., Ltd., Oxford Nanopore Technologies, PerkinElmer, Inc., QIAGEN N.V., SciGenom Labs Pvt. Ltd., Stratos Genomics (a Roche company), Thermo Fisher Scientific Inc., Veritas Genetics, and other key players, along with several other key players contributing to market growth through innovation, strategic partnerships, and global expansion.
- 1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
- 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
- 1.6.1. Open Sources
- 1.6.2. Paid Databases
- 1.6.3. Associations
- 1.7. Primary Research
- 1.7.1. Primary Sources
- 1.7.2. Primary Interviews with Stakeholders across Ecosystem
- 2. Executive Summary
- 2.1. Genomics Services Market Outlook
- 2.1.1. Genomics Services Market Size (Value - USD Bn), and Forecasts, 2021-2035
- 2.1.2. Compounded Annual Growth Rate Analysis
- 2.1.3. Growth Opportunity Analysis
- 2.1.4. Segmental Share Analysis
- 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
- 2.5.1. Customer/ End-use Industry Assessment
- 2.5.2. Growth Opportunity Data, 2025-2035
- 2.5.2.1. Regional Data
- 2.5.2.2. Country Data
- 2.5.2.3. Segmental Data
- 2.5.3. Identification of Potential Market Spaces
- 2.5.4. GAP Analysis
- 2.5.5. Potential Attractive Price Points
- 2.5.6. Prevailing Market Risks & Challenges
- 2.5.7. Preferred Sales & Marketing Strategies
- 2.5.8. Key Recommendations and Analysis
- 2.5.9. A Way Forward
- 3. Industry Data and Premium Insights
- 3.1. Genomics Services Industry Overview, 2025
- 3.1.1. Healthcare & Pharmaceutical Industry Ecosystem Analysis
- 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
- 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Source Roadmap and Developments
- 3.4. Trade Analysis
- 3.4.1. Import & Export Analysis, 2025
- 3.4.2. Top Importing Countries
- 3.4.3. Top Exporting Countries
- 3.5. Trump Tariff Impact Analysis
- 3.5.1. Manufacturer
- 3.5.2. Supply Chain
- 3.5.3. End Consumer
- 3.6. Raw Material Analysis
- 4. Market Overview
- 4.1. Market Dynamics
- 4.1.1. Drivers
- 4.1.1.1. Growth Driven by Real-Time Monitoring and Rising Research in Genomics Services Market
- 4.1.2. Restraints
- 4.1.2.1. Genomics Services Market Growth Challenged by Cost and Data Privacy Concerns
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
- 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
- 4.3.2. Tariffs and Standards
- 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
- 4.4.1. Raw Components Sourcing
- 4.4.2. Manufacturing and Processing
- 4.4.3. Wholesalers/ E-commerce Platform
- 4.4.4. End-use/ Customers
- 4.5. Cost Structure Analysis
- 4.5.1. Parameter’s Share for Cost Associated
- 4.5.2. COGP vs COGS
- 4.5.3. Profit Margin Analysis
- 4.6. Pricing Analysis
- 4.6.1. Regional Pricing Analysis
- 4.6.2. Segmental Pricing Trends
- 4.6.3. Factors Influencing Pricing
- 4.7. Porter’s Five Forces Analysis
- 4.8. PESTEL Analysis
- 4.9. Genomics Services Market Demand
- 4.9.1. Historical Market Size - (Value - USD Bn), 2021-2024
- 4.9.2. Current and Future Market Size - (Value - USD Bn), 2025–2035
- 4.9.2.1. Y-o-Y Growth Trends
- 4.9.2.2. Absolute $ Opportunity Assessment
- 5. Competition Landscape
- 5.1. Competition structure
- 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
- 5.2.1. Global Company Market Share
- 5.2.2. By Region
- 5.2.2.1. North America
- 5.2.2.2. Europe
- 5.2.2.3. Asia Pacific
- 5.2.2.4. Middle East
- 5.2.2.5. Africa
- 5.2.2.6. South America
- 5.3. Product Comparison Matrix
- 5.3.1. Specifications
- 5.3.2. Market Positioning
- 5.3.3. Pricing
- 6. Genomics Services Market Analysis, by Type of Service
- 6.1. Key Segment Analysis
- 6.2. Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, by Type of Service, 2021-2035
- 6.2.1. Sequencing Services
- 6.2.2. Microarray Services
- 6.2.3. Bioinformatics Services
- 6.2.4. Others (e.g., PCR, NGS Library Preparation)
- 7. Genomics Services Market Analysis, by Technology
- 7.1. Key Segment Analysis
- 7.2. Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, by Technology, 2021-2035
- 7.2.1. Next-Generation Sequencing (NGS)
- 7.2.2. Sanger Sequencing
- 7.2.3. Microarray
- 7.2.4. PCR
- 7.2.5. Others
- 8. Genomics Services Market Analysis, by Research Type
- 8.1. Key Segment Analysis
- 8.2. Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, by Research Type, 2021-2035
- 8.2.1. Functional Genomics
- 8.2.2. Epigenomics
- 8.2.3. Metagenomics
- 8.2.4. Transcriptomics
- 8.2.5. Proteomics
- 8.2.6. Others
- 9. Genomics Services Market Analysis, by Mode of Delivery
- 9.1. Key Segment Analysis
- 9.2. Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, by Mode of Delivery, 2021-2035
- 9.2.1. On-site Services
- 9.2.2. Off-site Services
- 10. Genomics Services Market Analysis, by Business Model
- 10.1. Key Segment Analysis
- 10.2. Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, by Business Model, 2021-2035
- 10.2.1. Outsourced Services
- 10.2.2. In-house Services
- 11. Genomics Services Market Analysis, by Application
- 11.1. Key Segment Analysis
- 11.2. Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, by Application, 2021-2035
- 11.2.1. Drug Discovery and Development
- 11.2.2. Diagnostics
- 11.2.3. Agriculture and Animal Research
- 11.2.4. Personalized Medicine
- 11.2.5. Others
- 12. Genomics Services Market Analysis, by End User
- 12.1. Key Segment Analysis
- 12.2. Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, by End User, 2021-2035
- 12.2.1. Hospitals and Clinics
- 12.2.2. Academic and Research Institutions
- 12.2.3. Pharmaceutical and Biotechnology Companies
- 12.2.4. Diagnostic Laboratories
- 12.2.5. Others
- 13. Genomics Services Market Analysis and Forecasts, by Region
- 13.1. Key Findings
- 13.2. Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, by Region, 2021-2035
- 13.2.1. North America
- 13.2.2. Europe
- 13.2.3. Asia Pacific
- 13.2.4. Middle East
- 13.2.5. Africa
- 13.2.6. South America
- 14. North America Genomics Services Market Analysis
- 14.1. Key Segment Analysis
- 14.2. Regional Snapshot
- 14.3. North America Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, 2021-2035
- 14.3.1. Type of Service
- 14.3.2. Technology
- 14.3.3. Research Type
- 14.3.4. Mode of Delivery
- 14.3.5. Business Model
- 14.3.6. Application
- 14.3.7. End User
- 14.3.8. Country
- 14.3.8.1. USA
- 14.3.8.2. Canada
- 14.3.8.3. Mexico
- 14.4. USA Genomics Services Market
- 14.4.1. Country Segmental Analysis
- 14.4.2. Type of Service
- 14.4.3. Technology
- 14.4.4. Research Type
- 14.4.5. Mode of Delivery
- 14.4.6. Business Model
- 14.4.7. Application
- 14.4.8. End User
- 14.5. Canada Genomics Services Market
- 14.5.1. Country Segmental Analysis
- 14.5.2. Type of Service
- 14.5.3. Technology
- 14.5.4. Research Type
- 14.5.5. Mode of Delivery
- 14.5.6. Business Model
- 14.5.7. Application
- 14.5.8. End User
- 14.6. Mexico Genomics Services Market
- 14.6.1. Country Segmental Analysis
- 14.6.2. Type of Service
- 14.6.3. Technology
- 14.6.4. Research Type
- 14.6.5. Mode of Delivery
- 14.6.6. Business Model
- 14.6.7. Application
- 14.6.8. End User
- 15. Europe Genomics Services Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. Europe Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, 2021-2035
- 15.3.1. Type of Service
- 15.3.2. Technology
- 15.3.3. Research Type
- 15.3.4. Mode of Delivery
- 15.3.5. Business Model
- 15.3.6. Application
- 15.3.7. End User
- 15.3.8. Country
- 15.3.8.1. Germany
- 15.3.8.2. United Kingdom
- 15.3.8.3. France
- 15.3.8.4. Italy
- 15.3.8.5. Spain
- 15.3.8.6. Netherlands
- 15.3.8.7. Nordic Countries
- 15.3.8.8. Poland
- 15.3.8.9. Russia & CIS
- 15.3.8.10. Rest of Europe
- 15.4. Germany Genomics Services Market
- 15.4.1. Country Segmental Analysis
- 15.4.2. Type of Service
- 15.4.3. Technology
- 15.4.4. Research Type
- 15.4.5. Mode of Delivery
- 15.4.6. Business Model
- 15.4.7. Application
- 15.4.8. End User
- 15.5. United Kingdom Genomics Services Market
- 15.5.1. Country Segmental Analysis
- 15.5.2. Type of Service
- 15.5.3. Technology
- 15.5.4. Research Type
- 15.5.5. Mode of Delivery
- 15.5.6. Business Model
- 15.5.7. Application
- 15.5.8. End User
- 15.6. France Genomics Services Market
- 15.6.1. Country Segmental Analysis
- 15.6.2. Type of Service
- 15.6.3. Technology
- 15.6.4. Research Type
- 15.6.5. Mode of Delivery
- 15.6.6. Business Model
- 15.6.7. Application
- 15.6.8. End User
- 15.7. Italy Genomics Services Market
- 15.7.1. Country Segmental Analysis
- 15.7.2. Type of Service
- 15.7.3. Technology
- 15.7.4. Research Type
- 15.7.5. Mode of Delivery
- 15.7.6. Business Model
- 15.7.7. Application
- 15.7.8. End User
- 15.8. Spain Genomics Services Market
- 15.8.1. Country Segmental Analysis
- 15.8.2. Type of Service
- 15.8.3. Technology
- 15.8.4. Research Type
- 15.8.5. Mode of Delivery
- 15.8.6. Business Model
- 15.8.7. Application
- 15.8.8. End User
- 15.9. Netherlands Genomics Services Market
- 15.9.1. Country Segmental Analysis
- 15.9.2. Type of Service
- 15.9.3. Technology
- 15.9.4. Research Type
- 15.9.5. Mode of Delivery
- 15.9.6. Business Model
- 15.9.7. Application
- 15.9.8. End User
- 15.10. Nordic Countries Genomics Services Market
- 15.10.1. Country Segmental Analysis
- 15.10.2. Type of Service
- 15.10.3. Technology
- 15.10.4. Research Type
- 15.10.5. Mode of Delivery
- 15.10.6. Business Model
- 15.10.7. Application
- 15.10.8. End User
- 15.11. Poland Genomics Services Market
- 15.11.1. Country Segmental Analysis
- 15.11.2. Type of Service
- 15.11.3. Technology
- 15.11.4. Research Type
- 15.11.5. Mode of Delivery
- 15.11.6. Business Model
- 15.11.7. Application
- 15.11.8. End User
- 15.12. Russia & CIS Genomics Services Market
- 15.12.1. Country Segmental Analysis
- 15.12.2. Type of Service
- 15.12.3. Technology
- 15.12.4. Research Type
- 15.12.5. Mode of Delivery
- 15.12.6. Business Model
- 15.12.7. Application
- 15.12.8. End User
- 15.13. Rest of Europe Genomics Services Market
- 15.13.1. Country Segmental Analysis
- 15.13.2. Type of Service
- 15.13.3. Technology
- 15.13.4. Research Type
- 15.13.5. Mode of Delivery
- 15.13.6. Business Model
- 15.13.7. Application
- 15.13.8. End User
- 16. Asia Pacific Genomics Services Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. East Asia Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, 2021-2035
- 16.3.1. Type of Service
- 16.3.2. Technology
- 16.3.3. Research Type
- 16.3.4. Mode of Delivery
- 16.3.5. Business Model
- 16.3.6. Application
- 16.3.7. End User
- 16.3.8. Country
- 16.3.8.1. China
- 16.3.8.2. India
- 16.3.8.3. Japan
- 16.3.8.4. South Korea
- 16.3.8.5. Australia and New Zealand
- 16.3.8.6. Indonesia
- 16.3.8.7. Malaysia
- 16.3.8.8. Thailand
- 16.3.8.9. Vietnam
- 16.3.8.10. Rest of Asia-Pacific
- 16.4. China Genomics Services Market
- 16.4.1. Country Segmental Analysis
- 16.4.2. Type of Service
- 16.4.3. Technology
- 16.4.4. Research Type
- 16.4.5. Mode of Delivery
- 16.4.6. Business Model
- 16.4.7. Application
- 16.4.8. End User
- 16.5. India Genomics Services Market
- 16.5.1. Country Segmental Analysis
- 16.5.2. Type of Service
- 16.5.3. Technology
- 16.5.4. Research Type
- 16.5.5. Mode of Delivery
- 16.5.6. Business Model
- 16.5.7. Application
- 16.5.8. End User
- 16.6. Japan Genomics Services Market
- 16.6.1. Country Segmental Analysis
- 16.6.2. Type of Service
- 16.6.3. Technology
- 16.6.4. Research Type
- 16.6.5. Mode of Delivery
- 16.6.6. Business Model
- 16.6.7. Application
- 16.6.8. End User
- 16.7. South Korea Genomics Services Market
- 16.7.1. Country Segmental Analysis
- 16.7.2. Type of Service
- 16.7.3. Technology
- 16.7.4. Research Type
- 16.7.5. Mode of Delivery
- 16.7.6. Business Model
- 16.7.7. Application
- 16.7.8. End User
- 16.8. Australia and New Zealand Genomics Services Market
- 16.8.1. Country Segmental Analysis
- 16.8.2. Type of Service
- 16.8.3. Technology
- 16.8.4. Research Type
- 16.8.5. Mode of Delivery
- 16.8.6. Business Model
- 16.8.7. Application
- 16.8.8. End User
- 16.9. Indonesia Genomics Services Market
- 16.9.1. Country Segmental Analysis
- 16.9.2. Type of Service
- 16.9.3. Technology
- 16.9.4. Research Type
- 16.9.5. Mode of Delivery
- 16.9.6. Business Model
- 16.9.7. Application
- 16.9.8. End User
- 16.10. Malaysia Genomics Services Market
- 16.10.1. Country Segmental Analysis
- 16.10.2. Type of Service
- 16.10.3. Technology
- 16.10.4. Research Type
- 16.10.5. Mode of Delivery
- 16.10.6. Business Model
- 16.10.7. Application
- 16.10.8. End User
- 16.11. Thailand Genomics Services Market
- 16.11.1. Country Segmental Analysis
- 16.11.2. Type of Service
- 16.11.3. Technology
- 16.11.4. Research Type
- 16.11.5. Mode of Delivery
- 16.11.6. Business Model
- 16.11.7. Application
- 16.11.8. End User
- 16.12. Vietnam Genomics Services Market
- 16.12.1. Country Segmental Analysis
- 16.12.2. Type of Service
- 16.12.3. Technology
- 16.12.4. Research Type
- 16.12.5. Mode of Delivery
- 16.12.6. Business Model
- 16.12.7. Application
- 16.12.8. End User
- 16.13. Rest of Asia Pacific Genomics Services Market
- 16.13.1. Country Segmental Analysis
- 16.13.2. Type of Service
- 16.13.3. Technology
- 16.13.4. Research Type
- 16.13.5. Mode of Delivery
- 16.13.6. Business Model
- 16.13.7. Application
- 16.13.8. End User
- 17. Middle East Genomics Services Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Middle East Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, 2021-2035
- 17.3.1. Type of Service
- 17.3.2. Technology
- 17.3.3. Research Type
- 17.3.4. Mode of Delivery
- 17.3.5. Business Model
- 17.3.6. Application
- 17.3.7. End User
- 17.3.8. Country
- 17.3.8.1. Turkey
- 17.3.8.2. UAE
- 17.3.8.3. Saudi Arabia
- 17.3.8.4. Israel
- 17.3.8.5. Rest of Middle East
- 17.4. Turkey Genomics Services Market
- 17.4.1. Country Segmental Analysis
- 17.4.2. Type of Service
- 17.4.3. Technology
- 17.4.4. Research Type
- 17.4.5. Mode of Delivery
- 17.4.6. Business Model
- 17.4.7. Application
- 17.4.8. End User
- 17.5. UAE Genomics Services Market
- 17.5.1. Country Segmental Analysis
- 17.5.2. Type of Service
- 17.5.3. Technology
- 17.5.4. Research Type
- 17.5.5. Mode of Delivery
- 17.5.6. Business Model
- 17.5.7. Application
- 17.5.8. End User
- 17.6. Saudi Arabia Genomics Services Market
- 17.6.1. Country Segmental Analysis
- 17.6.2. Type of Service
- 17.6.3. Technology
- 17.6.4. Research Type
- 17.6.5. Mode of Delivery
- 17.6.6. Business Model
- 17.6.7. Application
- 17.6.8. End User
- 17.7. Israel Genomics Services Market
- 17.7.1. Country Segmental Analysis
- 17.7.2. Type of Service
- 17.7.3. Technology
- 17.7.4. Research Type
- 17.7.5. Mode of Delivery
- 17.7.6. Business Model
- 17.7.7. Application
- 17.7.8. End User
- 17.8. Rest of Middle East Genomics Services Market
- 17.8.1. Country Segmental Analysis
- 17.8.2. Type of Service
- 17.8.3. Technology
- 17.8.4. Research Type
- 17.8.5. Mode of Delivery
- 17.8.6. Business Model
- 17.8.7. Application
- 17.8.8. End User
- 18. Africa Genomics Services Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. Africa Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, 2021-2035
- 18.3.1. Type of Service
- 18.3.2. Technology
- 18.3.3. Research Type
- 18.3.4. Mode of Delivery
- 18.3.5. Business Model
- 18.3.6. Application
- 18.3.7. End User
- 18.3.8. Country
- 18.3.8.1. South Africa
- 18.3.8.2. Egypt
- 18.3.8.3. Nigeria
- 18.3.8.4. Algeria
- 18.3.8.5. Rest of Africa
- 18.4. South Africa Genomics Services Market
- 18.4.1. Country Segmental Analysis
- 18.4.2. Type of Service
- 18.4.3. Technology
- 18.4.4. Research Type
- 18.4.5. Mode of Delivery
- 18.4.6. Business Model
- 18.4.7. Application
- 18.4.8. End User
- 18.5. Egypt Genomics Services Market
- 18.5.1. Country Segmental Analysis
- 18.5.2. Type of Service
- 18.5.3. Technology
- 18.5.4. Research Type
- 18.5.5. Mode of Delivery
- 18.5.6. Business Model
- 18.5.7. Application
- 18.5.8. End User
- 18.6. Nigeria Genomics Services Market
- 18.6.1. Country Segmental Analysis
- 18.6.2. Type of Service
- 18.6.3. Technology
- 18.6.4. Research Type
- 18.6.5. Mode of Delivery
- 18.6.6. Business Model
- 18.6.7. Application
- 18.6.8. End User
- 18.7. Algeria Genomics Services Market
- 18.7.1. Country Segmental Analysis
- 18.7.2. Type of Service
- 18.7.3. Technology
- 18.7.4. Research Type
- 18.7.5. Mode of Delivery
- 18.7.6. Business Model
- 18.7.7. Application
- 18.7.8. End User
- 18.8. Rest of Africa Genomics Services Market
- 18.8.1. Country Segmental Analysis
- 18.8.2. Type of Service
- 18.8.3. Technology
- 18.8.4. Research Type
- 18.8.5. Mode of Delivery
- 18.8.6. Business Model
- 18.8.7. Application
- 18.8.8. End User
- 19. South America Genomics Services Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. Central and South Africa Genomics Services Market Size (Value - USD Bn) , Analysis, and Forecasts, 2021-2035
- 19.3.1. Type of Service
- 19.3.2. Technology
- 19.3.3. Research Type
- 19.3.4. Mode of Delivery
- 19.3.5. Business Model
- 19.3.6. Application
- 19.3.7. End User
- 19.3.8. Country
- 19.3.8.1. Brazil
- 19.3.8.2. Argentina
- 19.3.8.3. Rest of South America
- 19.4. Brazil Genomics Services Market
- 19.4.1. Country Segmental Analysis
- 19.4.2. Type of Service
- 19.4.3. Technology
- 19.4.4. Research Type
- 19.4.5. Mode of Delivery
- 19.4.6. Business Model
- 19.4.7. Application
- 19.4.8. End User
- 19.5. Argentina Genomics Services Market
- 19.5.1. Country Segmental Analysis
- 19.5.2. Type of Service
- 19.5.3. Technology
- 19.5.4. Research Type
- 19.5.5. Mode of Delivery
- 19.5.6. Business Model
- 19.5.7. Application
- 19.5.8. End User
- 19.6. Rest of South America Genomics Services Market
- 19.6.1. Country Segmental Analysis
- 19.6.2. Type of Service
- 19.6.3. Technology
- 19.6.4. Research Type
- 19.6.5. Mode of Delivery
- 19.6.6. Business Model
- 19.6.7. Application
- 19.6.8. End User
- 20. Key Players/ Company Profile
- 20.1. Agilent Technologies, Inc.
- 20.1.1. Company Details/ Overview
- 20.1.2. Company Financials
- 20.1.3. Key Customers and Competitors
- 20.1.4. Business/ Industry Portfolio
- 20.1.5. Product Portfolio/ Specification Details
- 20.1.6. Pricing Data
- 20.1.7. Strategic Overview
- 20.1.8. Recent Developments
- 20.2. BaseClear B.V.
- 20.3. BGI Group
- 20.4. CD Genomics
- 20.5. CosmosID
- 20.6. Eurofins Scientific
- 20.7. F. Hoffmann-La Roche Ltd
- 20.8. Gene by Gene, Ltd.
- 20.9. Genewiz (A Brooks Life Sciences Company)
- 20.10. Illumina, Inc.
- 20.11. Macrogen Inc.
- 20.12. MedGenome Labs Ltd.
- 20.13. Novogene Co., Ltd.
- 20.14. Oxford Nanopore Technologies
- 20.15. PerkinElmer, Inc.
- 20.16. QIAGEN N.V.
- 20.17. SciGenom Labs Pvt. Ltd.
- 20.18. Stratos Genomics (a Roche company)
- 20.19. Thermo Fisher Scientific Inc.
- 20.20. Veritas Genetics
- 20.21. Other key Players
Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography